Filtered By:
Vaccination: Shingles (Herpes Zoster) Vaccine
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 1779 results found since Jan 2013.
Neuro-Ophthalmological Complications of the COVID-19 Vaccines: A Systematic Review
Conclusion:
Since the implementation of the COVID-19 vaccination campaign in the past year, several post-COVID-vaccination neuro-ophthalmological complications have been described. However, considering the number of individuals that have been exposed to the vaccines, the risk seems very low, and the clinical outcome in most cases is favorable. Therefore, on a population level, the benefits of the vaccines far outweigh the risk of neuro-ophthalmological complications.
Source: Journal of Neuro-Ophthalmology - May 27, 2022 Category: Opthalmology Tags: Disease of the Year 2021 Encore: COVID-19 Source Type: research
Neuro-ophthalmic complications of varicella-zoster virus
Curr Opin Ophthalmol. 2023 Aug 22. doi: 10.1097/ICU.0000000000000996. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: This review broadly describes recent neuro-ophthalmic manifestations of varicella-zoster virus (VZV) reported in literature.RECENT FINDINGS: Despite varicella vaccination, the incidence of herpes zoster continues to rise, potentially leading to devastating consequences when ocular complications occur.A small but growing literature documents cases of retinal disease because of varicella reactivation after SARS-CoV-2 vaccination, ischemic optic neuropathy occurring during herpes zoster ophthalmicus, VZV-indu...
Source: Herpes - August 21, 2023 Category: Infectious Diseases Authors: Toluwalase O Tofade Bart K Chwalisz Source Type: research
Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trial
Lancet Reg Health West Pac. 2023 Feb 18;34:100707. doi: 10.1016/j.lanwpc.2023.100707. eCollection 2023 May.ABSTRACTBACKGROUND: Despite the success in decreasing varicella-related disease burden, live-attenuated Oka vaccine strain of varicella-zoster virus (vOka) remains neuro-virulence and may establish latency and reactivate, raising safety concerns. Here we aimed to evaluate the safety and immunogenicity of a skin- and neuro-attenuated varicella vaccine candidate (v7D).METHODS: This is a randomized, double-blind, placebo-controlled, dose-escalation and age de-escalation phase 1 clinical trial conducted in Liuzhou, China ...
Source: Herpes - June 7, 2023 Category: Infectious Diseases Authors: Zhao-Jun Mo Shou-Jie Huang Ling-Xian Qiu Chang-Gui Li Xiao-Juan Yu Ming-Qiang Li Zhen Chen Guo-Hua Zhong De-Quan Pan Li-Rong Huang Bang-Jun Lv Xue-Lian Cui Qiao-Qiao Song Ji-Zong Jia Jin-Le Han Wei Wang Hua Zhu Tong Cheng Ying-Ying Su Yi-Min Li Xiang-Zhon Source Type: research
Evaluating public interest in herpes zoster in Germany by leveraging the internet: a retrospective search data analysis
CONCLUSIONS: The study demonstrated that evaluating internet search data is a viable method for assessing public interest in HZ, thereby identifying areas of unmet need to support targeted public health campaigns.PMID:37580664 | DOI:10.1186/s12889-023-16463-4
Source: Herpes - August 14, 2023 Category: Infectious Diseases Authors: Alphina Kain Linda Tizek Hannah Wecker Fabian Walln öfer Tilo Biedermann Alexander Zink Source Type: research
Neurological and Ophthalmological Manifestations of Varicella Zoster Virus
Conclusions:
HZ produces a spectrum of potentially blinding and life-threatening complications that adversely affect quality of life and increase health care costs. Individuals at risk for HZ, such as the elderly and immunocompromised, should be encouraged to receive the highly effective VZV vaccine to prevent HZ and its complications.
Source: Journal of Neuro-Ophthalmology - May 21, 2019 Category: Opthalmology Tags: State-of-the-Art Review Source Type: research
Development of a skin- and neuro-attenuated live vaccine for varicella
Nat Commun. 2022 Feb 11;13(1):824. doi: 10.1038/s41467-022-28329-1.ABSTRACTVaricella caused by the primary infection of varicella-zoster virus (VZV) exerts a considerable disease burden globally. Current varicella vaccines consisting of the live-attenuated vOka strain of VZV are generally safe and effective. However, vOka retains full neurovirulence and can establish latency and reactivate to cause herpes zoster in vaccine recipients, raising safety concerns. Here, we rationally design a live-attenuated varicella vaccine candidate, v7D. This virus replicates like wild-type virus in MRC-5 fibroblasts and human PBMCs, the ca...
Source: Herpes - February 12, 2022 Category: Infectious Diseases Authors: Wei Wang Dequan Pan Wenkun Fu Xiangzhong Ye Jinle Han Lianwei Yang Jizong Jia Jian Liu Rui Zhu Yali Zhang Che Liu Jianghui Ye Anca Selariu Yuqiong Que Qinjian Zhao Ting Wu Yimin Li Jun Zhang Tong Cheng Hua Zhu Ningshao Xia Source Type: research
Herpes zoster and the search for an effective vaccine.
This article reviews VZV pathogenesis, host responses and current vaccines available to prevent herpes zoster. This article is protected by copyright. All rights reserved.
PMID: 27164323 [PubMed - as supplied by publisher]
Source: Clinical and Developmental Immunology - May 9, 2016 Category: Allergy & Immunology Authors: Arnold N, Messaoudi I Tags: Clin Exp Immunol Source Type: research
Vaccination against the herpes zoster virus
CONCLUSIONS: We have a safe and effective vaccine against the herpes zoster virus that allows us to protect the most vulnerable population groups against this virus.PMID:37573820 | PMC:PMC10428030 | DOI:10.1016/j.aprim.2023.102710
Source: Atencion Primaria - August 13, 2023 Category: Primary Care Authors: Jos é Javier Gómez Marco Susana Mart ín Martín Pablo Aldaz Herce Ana Pilar Javierre Miranda Coro S ánchez Hernández Source Type: research
